Understand any stock in simple English
RadNet runs outpatient medical imaging centers and sells the software that helps radiology practices manage their work.
RadNet is a big owner of outpatient imaging centers in the United States. If your doctor sends you for an MRI, a CT scan, or a mammogram, there is a good chance RadNet runs the place where you get it — a standalone clinic rather than a hospital. It operates hundreds of these centers across the country, and it also sells a growing set of software products for radiology practices and health systems.
The center business is the core, and it is straightforward: insurers and patients pay for scans. Volume drives everything. Fewer scans per patient and steady reimbursement work against the company, which led to a tough stretch in 2025. The company cut its revenue and earnings guidance twice, blamed a drop in procedure volume, and the stock fell sharply. So this is a business with real operating leverage — small changes in scans read and paid for move profits a lot. The software arm, which RadNet calls its digital health business, sells tools for radiology and has been growing fast. It also signed an unusual, high-profile deal: an agreement with Nvidia to develop AI for medical imaging. The software and AI push is partly about the future and partly about doing more with the same scans — better scheduling, cleaner data, more useful images.
Why does RadNet matter? Reading an x-ray generates a picture, but the value comes from fast, reliable, well-run imaging. The company's scale and its software let it offer this to both doctors and hospitals. The tension is that it depends on reimbursements and on how many scans insured patients actually get. That makes it partly a health-care service business and partly a bet on radiology software. It is important here to be honest: this is a business that grows with procedure volume, and when volume sags, it can hurt.
Saved answer · last researched 17 Nov 2026